Both cases provide further evidence for the gynaecological cancer risk from mosaicism of BRCA1/BRCA2, which has so far only been reported in a single case of BRCA2 mosaicism in a woman with ovarian cancer [10]. This evidence concerns the gene BRCA1 and ovarian cancer.